Clinical Trial Update: Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating afatinib in combination with postoperative radiation therapy for squamous cell carcinoma of the head and neck; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Status: COMPLETED